Human Genome Epidemiology Literature Finder
Rare Diseases
Records 1 - 23 (of 23 Records) |
Query Trace: Oligoastrocytoma[original query] |
---|
Associations between ERCC2 polymorphisms and gliomas. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001 Apr 10 (4): 355-60. Caggana M, Kilgallen J, Conroy J M, Wiencke J K, Kelsey K T, Miike R, Chen P, Wrensch M |
Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2002 1 8 (1): 196-201. Ueki Keisuke, Nishikawa Ryo, Nakazato Yoichi, Hirose Takanori, Hirato Junko, Funada Nobuaki, Fujimaki Takamitsu, Hojo Shuntaro, Kubo Osami, Ide Takafumi, Usui Masaaki, Ochiai Chikayuki, Ito Shoichi, Takahashi Hiroshi, Mukasa Akitake, Asai Akio, Kirino Takaa |
Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 2004 Apr 10 (8): 2618-25. Okcu MF, Selvan M, Wang LE, Stout L, Erana R, Airewele G, Adatto P, Hess K, Ali-Osman F, Groves M, Yung AW, Levin VA, Wei Q, Bondy M |
Glutathione-S-transferase variants and adult glioma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004 Mar 13 (3): 461-7. Wrensch M, Kelsey KT, Liu M, Miike R, Moghadassi M, Aldape K, McMillan A, Wiencke JK |
Molecular classification of low-grade diffuse gliomas. The American journal of pathology 2010 Dec 177 (6): 2708-14. Kim Young-Ho, Nobusawa Sumihito, Mittelbronn Michel, Paulus Werner, Brokinkel Benjamin, Keyvani Kathy, Sure Ulrich, Wrede Karsten, Nakazato Yoichi, Tanaka Yuko, Vital Anne, Mariani Luigi, Stawski Robert, Watanabe Takuya, De Girolami Umberto, Kleihues Paul, Ohgaki Hiro |
Molecular markers in low-grade gliomas: predictive or prognostic? Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Jul 17 (13): 4588-99. Hartmann Christian, Hentschel Bettina, Tatagiba Marcos, Schramm Johannes, Schnell Oliver, Seidel Clemens, Stein Robert, Reifenberger Guido, Pietsch Torsten, von Deimling Andreas, Loeffler Markus, Weller Michael, |
An analysis of the prognostic value of IDH1 (isocitrate dehydrogenase 1) mutation in Polish glioma patients. Molecular diagnosis & therapy 2014 Feb 18 (1): 45-53. Lewandowska Marzena Anna, Furtak Jacek, Szylberg Tadeusz, Roszkowski Krzysztof, Windorbska Wies?awa, Rytlewska Joanna, Jó?wicki Wojcie |
[Relationship between IDH1 mutation and clinic pathologic features in human supratentorial WHO grade II gliomas]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 2013 Jan 44 (1): 60-3. Tang Jun-Jia, Xie Fei, Wang Xiang, Zhang Dou-Dou, Liu Shuang, Liu Yan-Hui, Mao Qi |
1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas. Neuro-oncology 2013 Mar . Jiang H, Ren X, Cui X, Wang J, Jia W, Zhou Z, Lin S |
Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China. Journal of cancer research and clinical oncology 2014 Jan 140 (1): 45-51. Zhang Chuan-Bao, Bao Zhao-Shi, Wang Hong-Jun, Yan Wei, Liu Yan-Wei, Li Ming-Yang, Zhang Wei, Chen Ling, Jiang T |
Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients. Asian Pacific journal of cancer prevention : APJCP 2013 14 (12): 7261-4. Das Bibhu Ranjan, Tangri Rajiv, Ahmad Firoz, Roy Arnab, Patole Kamlak |
Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene. Genes, chromosomes & cancer 2015 Nov 54 (11): 655-67. Lhotska Halka, Zemanova Zuzana, Cechova Hana, Ransdorfova Sarka, Lizcova Libuse, Kramar Filip, Krejcik Zdenek, Svobodova Karla, Bystricka Dagmar, Hrabal Petr, Dohnalova Alena, Michalova Ky |
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas. Oncotarget 2015 Jul . Leeper Heather E, Caron Alissa A, Decker Paul A, Jenkins Robert B, Lachance Daniel H, Giannini Cateri |
IDH1 and IDH2 mutations in different histologic subtypes and WHO grading gliomas in a sample from Northern Brazil. Genetics and molecular research : GMR 2015 14 (2): 6533-42. Pessôa I A, Sagica F E S, Anselmo N P, Brito J R N, de Oliveira E H |
Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas. Neuropathology : official journal of the Japanese Society of Neuropathology 2015 Aug 35 (4): 324-35. Ogura Ryosuke, Tsukamoto Yoshihiro, Natsumeda Manabu, Isogawa Mizuho, Aoki Hiroshi, Kobayashi Tsutomu, Yoshida Seiichi, Okamoto Kouichiro, Takahashi Hitoshi, Fujii Yukihiko, Kakita Akiyos |
Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach. Journal of clinical pathology 2016 Jan . Rajmohan K S, Sugur Harsha S, Shwetha S D, Ramesh Arvind, Thennarasu Kandavel, Pandey Paritosh, Arivazhagan Arimappamagan, Santosh Va |
Prognostic markers for survival in patients with oligodendroglial tumors; a single-institution review of 214 cases. PloS one 2017 11 12 (11): e0188419. Zetterling Maria, Berhane Luwam, Alafuzoff Irina, Jakola Asgeir S, Smits An |
von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53. Brain tumor research and treatment 2019 Apr 7 (1): 33-38. Lehrer Steven, Rheinstein Peter H, Green Sheryl, Rosenzweig Kenneth |
Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma. PeerJ 2019 7 e7414. Zhu Jin, Zhang Yu- |
Allergy may confer better survival on patients with gliomas. Clinical neurology and neurosurgery 2019 1 177 63-67. Lehrer Steven, Rheinstein Peter H, Rosenzweig Kenneth |
High IER5 Gene Expression Is Associated With Poor Prognosis in Glioma Patients. Frontiers in cell and developmental biology 2021 7 9 679684. Wu Zijun, Wang Dan, Zeng Fanxin, Zhang Yanrong, Zhu Guannan, Ma Yiqi, Song Bin, Lui Su, Wu M |
Prognostic Role of EYA4 in Lower Grade Glioma with IDH1 Mutation and 1p19q Co-Deletion. World neurosurgery 2021 2 149 e1174-e1179. Zhu Jin, Hu Li-Bo, Zhao Ya-Peng, Zhang Yu- |
Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis. Scientific reports 2023 5 13 (1): 6761. Kwanghoon Lee, Seong-Ik Kim, Eric Eunshik Kim, Yu-Mi Shim, Jae-Kyung Won, Chul-Kee Park, Seung Hong Choi, Hongseok Yun, Hyunju Lee, Sung-Hye Pa |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: